Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,432
Recruiting: 781
Ph III recruiting: 109
Growth YoY: +20.5%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 251–300 of 671 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03097939	Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma	active not recruiting	Phase 2	113	National Cancer Centre, SingaporeOTHER	1	Jun 22, 2026	clinicaltrials
NCT03476681	Study of NEO-201 in Solid Tumors Expansion Cohorts	active not recruiting	Phase 1 / Phase 2	121	Precision Biologics, IncINDUSTRY	1	Jun 22, 2026	clinicaltrials